KIM BERGHAUS: Open Payments
NPI 1396062857 · SHEPHERDSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Exact Sciences Corporation | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Kerendia, Auvelity, Ozempic, ZORYVE, Rybelsus, The Cologuard Plus Collection Kit, OTEZLA, JARDIANCE.
Industry payments across KY — which companies pay providers there.
